Skip to content
Ranked #542
AM Rx

Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).

semaglutide
$151/moquarterly term
tirzepatide
Not confirmed for AM Rx.

FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.

Before enrolling

Active FTC/DOJ lawsuit over deceptive billing and subscription practices

vs
Ranked #91Desk pick
FitRx

Insured patients seeking brand-name GLP-1 access with compounded fallback.

semaglutide
$151/moquarterly term
tirzepatide
Not confirmed for FitRx.

FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.

Before enrolling

Insurance coordination may not work for all plans

Our review of FitRx gives it 78/100 (C+), while our review of AM Rx gives it 42/100 (C). The score breakdown shows where each provider does better.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

AM Rx

42/100

C

Overall

FitRx

78/100

C+

Price transparency

20
76

State access

24
86

Molecule range

79
79

Onboarding speed

66
82

Support responsiveness

52
76

Licensing & trust

21
66

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldAM RxFitRx
Semaglutide$151/moquarterly term
Full plan terms

$151/mo (quarterly plan, plus a separate fee, compounded)

$151/moquarterly term
Full plan terms

$151/mo (quarterly plan, compounded)

TirzepatideNot confirmed for AM Rx.Not confirmed for FitRx.
CoverageNot confirmed for AM Rx.All 50 states
Brand-nameBrand-name option listedBrand-name option listed
Oral optionNot confirmed hereNot confirmed here
Best forPatients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).Insured patients seeking brand-name GLP-1 access with compounded fallback.
Desk Score42/100C78/100C+

The verdict

Desk pick — FitRx

FitRx has the higher Desk Score, but AM Rx may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.

Choose AM Rx if…

Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).

$151/mo (quarterly term) sema

FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.

Choose FitRx if…

Insured patients seeking brand-name GLP-1 access with compounded fallback.

$151/mo (quarterly term) sema · All 50 states

FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.